Massachusetts General Hospital in Boston, USA, announced that the first person to undergo a genetically modified pig kidney transplant died two months after the procedure. The hospital stated on Saturday evening, "The staff at Massachusetts General Hospital is deeply saddened by the sudden passing of Mr. Rick Sleeman. We have no evidence that this event was a result of the recent transplant procedure." Surgeons at Massachusetts General Hospital successfully transplanted the genetically modified pig kidney into Sleeman, who was 62 years old at the time and suffering from acute kidney disease, and was on the brink of death. The hospital's statement added, "Sleeman will forever be a beacon of hope for countless kidney transplant patients around the world, and we are deeply grateful for his trust in us and his willingness to advance the field of xenotransplantation." The shortage of organs for transplantation is a major issue worldwide, with Massachusetts General Hospital stating in March that over 1,400 patients were on its waiting list for kidney transplants.
The First Patient to Receive a Genetically Modified Pig Kidney Transplant Has Died
Rick Sleeman, the first patient to receive a genetically modified pig kidney transplant, passed away two months after the surgery. Massachusetts General Hospital expressed condolences but stated there is no evidence linking his death to the transplant. This case highlights the ongoing global organ shortage and the potential of xenotransplantation.
👥 Key Players
📰 What Happened
Rick Sleeman, the first patient to receive a genetically modified pig kidney transplant, died two months after the surgery. The hospital stated there is no evidence linking his death to the transplant.
- Sleeman was suffering from acute kidney disease and was on the brink of death before the transplant.
- There is a significant global shortage of organs for transplantation, with over 1,400 patients on the waiting list at Massachusetts General Hospital.
💡 Why It Matters
📚 Background
Xenotransplantation involves transplanting organs from one species to another, which could alleviate the shortage of human organs for transplant. This field is still in its infancy and raises ethical and medical concerns.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%